THF-γ2, a synthetic thymic hormone, increases effectiveness of combined chemotherapy and immunotherapy against RPC-5 murine plasmacytoma

This publication has 11 references indexed in Scilit:

• Therapy of a fatal murine cytomegalovirus infection with thymic humoral factor (THF-γ2) treated immune spleen cells
  Clinical and Experimental Immunology, 1990
• Thymic humoral factor .gamma.2: purification and amino acid sequence of an immunoregulatory peptide from calf thymus
  Biochemistry, 1988
• RESTORATION OF IMMUNOLOGICAL RESPONSES BY THF, A THYMIC HORMONE, IN MICE INFECTED WITH MURINE CYTOMEGALOVIRUS (MCMV)
  1987
• Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer
  New England Journal of Medicine, 1985
• Effect of melphalan in vitro on induction of murine suppressor T cells by ConA
  Cancer Immunology, Immunotherapy, 1985
• Thymic hormones: inducers and
  Immunology Today, 1983
• Tumour immunoprophylaxis in mice using glutaraldehyde-treated syngeneic myeloma cells
  British Journal of Cancer, 1981
• The development of in vitro and in vivo anti-tumor cytotoxicity in noncytotoxic, MOPC-315-tumor-bearer, spleen cells ?educated? in vitro with MOPC-315 tumor cells
  Cancer Immunology, Immunotherapy, 1978
• Inhibition of syngeneic fibrosarcoma growth by lymphocytes sensitized on tumor-cell monolayers in the presence of the thymic humoral factor
  International Journal of Cancer, 1975
• STUDIES ON CHARACTERIZATION OF THE LYMPHOID TARGET CELL FOR ACTIVITY OF A THYMUS HUMORAL FACTOR
  The Journal of Experimental Medicine, 1973